Maximus, Inc. (MMS) Receives Consensus Rating of “Hold” from Analysts

Shares of Maximus, Inc. (NYSE:MMS) have been given an average recommendation of “Hold” by the eleven analysts that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and nine have issued a hold rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $61.00.

MMS has been the topic of several research reports. BidaskClub downgraded shares of Maximus from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 6th. Zacks Investment Research upgraded shares of Maximus from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research report on Saturday, August 5th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. Robert W. Baird reiterated a “hold” rating and set a $64.00 target price on shares of Maximus in a research report on Friday, September 1st. Finally, Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a research report on Tuesday, July 4th.

In related news, CEO Richard A. Montoni sold 29,203 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the sale, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at $33,161,601.70. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the sale, the general counsel now directly owns 13,716 shares of the company’s stock, valued at $807,735.24. The disclosure for this sale can be found here. Insiders have sold 125,403 shares of company stock worth $7,645,251 over the last quarter. 3.10% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Intl Fcstone Inc. bought a new stake in shares of Maximus during the second quarter worth approximately $201,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Maximus during the second quarter worth approximately $549,000. Public Employees Retirement System of Ohio raised its stake in shares of Maximus by 0.3% during the second quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock worth $4,588,000 after buying an additional 207 shares during the last quarter. Koch Industries Inc. bought a new stake in shares of Maximus during the second quarter worth approximately $629,000. Finally, Verition Fund Management LLC bought a new stake in shares of Maximus during the second quarter worth approximately $283,000. 97.23% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/09/18/maximus-inc-mms-receives-consensus-rating-of-hold-from-analysts.html.

Shares of Maximus (NYSE:MMS) traded down 0.46% during trading on Wednesday, hitting $63.29. 283,195 shares of the stock traded hands. The company has a market cap of $4.11 billion, a PE ratio of 20.29 and a beta of 1.37. Maximus has a one year low of $43.69 and a one year high of $64.97. The firm has a 50 day moving average price of $60.81 and a 200-day moving average price of $61.48.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The company had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. During the same quarter in the previous year, the firm posted $0.79 EPS. The business’s revenue was down 2.7% compared to the same quarter last year. Analysts anticipate that Maximus will post $3.13 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th were given a dividend of $0.045 per share. The ex-dividend date of this dividend was Friday, August 11th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. Maximus’s payout ratio is 5.73%.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Analyst Recommendations for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply